Back
Bristol Myers Squibb Co. Vs. Amgen, Inc. Industry Stock Comparison
Buy
73
BMY
Bristol Myers Squibb Co.
Last Price:
$56.73
Seasonality Move:
12.83%
Buy
52
AMGN
Amgen, Inc.
Last Price:
$341.64
Seasonality Move:
5.99%
Buy
73
Bristol Myers Squibb Co. (BMY)
is a Buy
Is Bristol Myers Squibb Co. a Buy, Sell or Hold?
-
The current Bristol Myers Squibb Co. [BMY] share price is $56.72. The Score for BMY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
BMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Amgen, Inc. (AMGN)
is a Buy
Is Amgen, Inc. a Buy, Sell or Hold?
-
The current Amgen, Inc. [AMGN] share price is $341.64. The Score for AMGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
AMGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMY Stock Price Chart
What is Bristol Myers Squibb Co.'s stock price today?
-
The Bristol Myers Squibb Co. share price today is $56.72Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMGN Stock Price Chart
What is Amgen, Inc.'s stock price today?
-
The Amgen, Inc. share price today is $341.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 71.58 | Buy |
| Chaikin Money Flow: | 17563664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.38 - 54.88) | Buy |
| Bollinger Bands (100): | (44.34 - 51.38) | Buy |
AMGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.55 | Buy |
| Relative Strength Index (14 RSI): | 62.44 | Buy |
| Chaikin Money Flow: | 2672430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (320.34 - 336.04) | Buy |
| Bollinger Bands (100): | (284.39 - 329.61) | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.32 | Buy |
| 20-day SMA: | 53.66 | Buy |
| 50-day SMA: | 49.94 | Buy |
| 200-day SMA: | 48.44 | Buy |
| 8-day EMA: | 54.52 | Buy |
| 20-day EMA: | 53.41 | Buy |
| 50-day EMA: | 50.92 | Buy |
| 200-day EMA: | 49.38 | Buy |
AMGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 329.84 | Buy |
| 20-day SMA: | 326.49 | Buy |
| 50-day SMA: | 325.89 | Buy |
| 200-day SMA: | 297.99 | Buy |
| 8-day EMA: | 330.79 | Buy |
| 20-day EMA: | 329.21 | Buy |
| 50-day EMA: | 323.3 | Buy |
| 200-day EMA: | 305.11 | Buy |
Bristol Myers Squibb Co. Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.16 per share.
Amgen, Inc. Earnings Growth & AMGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and an increase next year of $0.69 per share.
Bristol Myers Squibb Co. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amgen, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||